Home
Conditions
Meningitis, Bacterial

Clinical trial condition

Meningitis, Bacterial

Explore clinical trials studying Meningitis, Bacterial. Study availability and eligibility vary by location and protocol.

134 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Meningitis, Bacterial trial results

Completed

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

NCT00355121

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +31 more
Locations: Little Rock, Arkansas, United States

Boulder, Colorado, United States

Atlanta, Georgia, United States

Layton, UT 84041, Georgia, United States

View all 26 locations

View Trial Details

Completed

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

NCT00780806

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Pfizer Investigational Site Herston, Australia

Pfizer Investigational Site North Adelaide, Australia

Pfizer Investigational Site Subiaco, Australia

View Trial Details

Completed

Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

NCT00227214

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: A Coruña, Spain

Alcalá de Henares, Spain

Alcorcón, Spain

Arrasate / Mondragón, Spain

View all 39 locations

View Trial Details

Completed

Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine

NCT00994695

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Butajira Hospital Butajīra, Southern Nationality, Ethiopia

View Trial Details

Completed

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

NCT00297687

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Herson, Queensland, Australia

North Adealaide, South Australia, Australia

Perth, Western Australia, Australia

View Trial Details

Completed

Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis

NCT00162578

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Service de Réanimation Médicale, CHU Louis Mourier Colombes, France

Service de Réanimation Médicale, CHU Bichat Paris, France

Service de Réanimation Médicale, CHI Poissy-St-Germain Poissy, France

View Trial Details

Completed

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

NCT00271479

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations: Norwegian Institute of Public Health Oslo, Norway

Mbarara Epicentre Research Base Mbarara, Uganda

View Trial Details

Active, Not Recruiting

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

NCT05087056

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Ventura, California, United States

GSK Investigational Site Macon, Georgia, United States

GSK Investigational Site Valparaiso, Indiana, United States

View Trial Details

Active, Not Recruiting

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

NCT06113198

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: GSK Investigational Site Incheon, South Korea

GSK Investigational Site Junggu, South Korea

GSK Investigational Site Kyungki-do, South Korea

GSK Investigational Site Seongnam-si Gyeonggi-do, South Korea

View Trial Details

Active, Not Recruiting

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

NCT05935176

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Wuzhi County Center for Disease Control and Prevention Jiaozuo, Henan, China

View Trial Details

Meningitis, Bacterial

Meningitis, Bacterial trial results

Related conditions